Reaction
B-Cell Aplasia reporting signals
As of the last recalculation, B-Cell Aplasia appears in 251 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is AXICABTAGENE CILOLEUCEL (PRR 423.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Axicabtagene Ciloleucel | 42 | 423.6 | 425.5 |
| Blinatumomab | 31 | 281.0 | 281.8 |
| Fludarabine Phosphate | 48 | 124.9 | 125.1 |
| Thiotepa | 6 | 53.4 | 53.4 |
| Remdesivir | 6 | 38.2 | 38.2 |
| Carfilzomib | 10 | 30.5 | 30.5 |
| Ofatumumab | 10 | 25.9 | 26.0 |
| Polatuzumab Vedotin | 3 | 25.8 | 25.8 |